Highlights and Quick Summary
- Gross Profit Growth for the quarter ending June 30, 2023 was 1.02 (a -209.27% decrease compared to previous quarter)
- Year-over-year quarterly Gross Profit Growth decreased by -666.06%
- Annual Gross Profit Growth for 2022 was -0.59 (a -15972.97% decrease from previous year)
- Annual Gross Profit Growth for 2021 was 0.0 (a -99.31% decrease from previous year)
- Annual Gross Profit Growth for 2020 was 0.53 (a 15.62% increase from previous year)
Visit stockrow.com/EBS
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Gross Profit Growth of Emergent Biosolutions Inc.
Most recent Gross Profit Growthof EBS including historical data for past 10 years.Interactive Chart of Gross Profit Growth of Emergent Biosolutions Inc.
Emergent Biosolutions Inc. Gross Profit Growth for the past 10 Years (both Annual and Quarterly)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | 1.02 | -0.93 | – | – | – |
2022 | -0.78 | -0.18 | -0.57 | -0.38 | -0.59 |
2021 | 0.32 | -0.58 | -0.36 | 1.11 | 0.0 |
2020 | 0.7 | 0.3 | 0.86 | 0.17 | 0.53 |
2019 | 0.45 | 0.95 | 0.06 | 0.56 | 0.46 |
2018 | 0.2 | -0.01 | 1.04 | -0.1 | 0.23 |
2017 | 0.11 | 0.02 | 0.07 | -0.11 | 0.03 |
2016 | 0.03 | -0.16 | -0.38 | 0.76 | -0.05 |
2015 | 0.33 | 0.17 | 0.3 | 0.29 | 0.26 |
2014 | 0.1 | 0.53 | 0.16 | -0.07 | 0.21 |
2013 | -0.01 | 0.22 | 0.15 | -0.13 | 0.06 |
2012 | -0.15 | 0.17 | – | – | 0.02 |
Business Profile of Emergent Biosolutions Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic